FG
TMCI icon

Formula Growth’s Treace Medical Concepts TMCI Stock Holding History

Formula Growth’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-268,069
Closed -$3.5M – 125
2024
Q1 		$3.5M Sell
268,069
-110,000
-29% -$1.47M 1.12% 36
2023
Q4 		$4.82M Buy
378,069
+155,800
+70% +$1.57M 1.54% 7
2023
Q3 		$2.91M Buy
222,269
+104,519
+89% +$1.91M 0.99% 34
2023
Q2 		$3.01M Sell
117,750
-7,150
-6% -$185K 0.96% 36
2023
Q1 		$3.15M Buy
+124,900
New +$2.93M 1.01% 35

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Formula Growth's TMCI Position: Q2 2024 in Review

Formula Growth sold out of Treace Medical Concepts (TMCI) in Q2 2024, closing a stake of 268,069 shares — an estimated $3.5M sold.

Formula Growth first reported a position in TMCI in Q1 2023 and held it in 5 quarters. The position peaked at $4.82M in Q4 2023. 128 funds tracked by Wall St. Rank hold TMCI as of Q2 2024.

  • Formula Growth reported no remaining Treace Medical Concepts position as of Q2 2024 after selling out during the quarter.
  • Formula Growth sold 268,069 Treace Medical Concepts shares in Q2 2024, an estimated $3.5M.
  • Formula Growth first reported a position in Treace Medical Concepts in Q1 2023 and held it in 5 quarters.
  • Formula Growth's Treace Medical Concepts position peaked at $4.82M in Q4 2023.
  • 128 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2024.

Based on Formula Growth's 13F filing for Q2 2024, filed 13 Aug 2024.